As climate change intensifies, healthcare systems will increasingly face unprecedented climatic emergencies surpassing assumptions underlying their emergency protocols. While conventional scenario-based preparedness and contingency planning will remain relevant for most events, they may falter…
Continue Reading
What You Should Know:
– Proprio has secured FDA clearance for Picasso, its fourth cleared capability within the Paradigm AI surgical platform.
– The feature enables “trace-based” optical registration, allowing spine surgeons to perform real-time, radiation-free…
Continue Reading
What You Should Know
– Xella Health has emerged from stealth with $3.7M in pre-seed financing to build the infrastructure for “decoding” female biology.
– Led by Precursor Ventures, the company is pioneering a first-of-its-kind…
Continue Reading
We're excited to be back for another episode of the Life Sciences Today Podcast by Healthcare IT Today. My guest today is David Bates, Founder and CEO at Linus Health. I talk with David…
Continue Reading
What You Should Know:
– Paradigm Health’s acquisition of Flatiron Health’s Clinical Research Business, coupled with a long-term strategic partnership, marks a structural shift in how oncology trials are conducted and how patients across the country…
Continue Reading
P4 medicine (Predictive, Preventive, Personalized, and Participatory) offers a comprehensive approach to personalized healthcare, emphasizing both the transition from disease to wellness and the importance of preventive care. In this perspective, we propose a…
Continue Reading
Neuropsychiatric disorders have complex causes and exhibit considerable individual variability as they develop over time. This suggests the need for a shift from a focus on observable clinical symptoms to a personalized trajectory monitoring…
Continue Reading
Introduction: Revolutionary Healthcare Technology Support
Ochsner’s New Orleans-based Ochsner Health has revolutionized healthcare technology adoption by creating an innovative 70-person “sales team for tech” that has become indispensable to clinicians across their extensive network. This…
What You Should Know:
– Revalia Bio Inc., a new pre-clinical research company secures $14.5M in seed funding round to support the launch of its “Human Data Trials”.
– The funding was co-led by America’s Frontier…
Continue Reading
The Strategic Shift in Healthcare Technology Decisions
Hospital CEOs are fundamentally changing how they evaluate technology investments, moving away from technical specifications toward measurable business outcomes. This paradigm shift reflects a growing demand for accountability…
